Home Cart Sign in  
Chemical Structure| 18274-81-2 Chemical Structure| 18274-81-2

Structure of ADT-OH
CAS No.: 18274-81-2

Chemical Structure| 18274-81-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ADT-OH is a hydrogen sulfide-releasing donor that induces apoptosis by upregulating FADD and inhibits the in vivo progression of melanoma. It holds significant potential in cancer research, particularly in the treatment of melanoma.

Synonyms: 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione; ACS 1; Desmethylanethol trithione

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ADT-OH

CAS No. :18274-81-2
Formula : C9H6OS3
M.W : 226.34
SMILES Code : S=C1SSC(C2=CC=C(O)C=C2)=C1
Synonyms :
5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione; ACS 1; Desmethylanethol trithione
MDL No. :MFCD20922704
InChI Key :IWBBKLMHAILHAR-UHFFFAOYSA-N
Pubchem ID :3082127

Safety of ADT-OH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HK2 cells 6.3 μM and 12.5 μM 24 h ADT-OH significantly reduced cisplatin-induced cell death in HK2 cells and decreased apoptosis, ROS accumulation, and mitochondrial membrane potential decline. Redox Biol. 2024 Feb;69:102973
A375 cells 0.8-50 μM 24 h ADT-OH induced apoptosis in A375 cells, and this effect was reduced after FADD knockdown. Cell Death Dis. 2020 Jan 16;11(1):33
MEF cells 0.8-100 μM 24-72 h ADT-OH had a slight effect on the proliferation and apoptosis of MEF cells. Cell Death Dis. 2020 Jan 16;11(1):33
B16F10 cells 0.8-100 μM 24-72 h ADT-OH significantly inhibited the proliferation of B16F10 cells and induced apoptosis. Cell Death Dis. 2020 Jan 16;11(1):33
A375 cells 6.3 μM 24 h ADT-OH significantly inhibited the migration of A375 cells Acta Pharmacol Sin. 2022 Jul;43(7):1829-1842
B16F1 cells 6.3 μM 24 h ADT-OH significantly inhibited the migration of B16F1 cells Acta Pharmacol Sin. 2022 Jul;43(7):1829-1842
B16F10 cells 6.3 μM 24 h ADT-OH significantly inhibited the migration of B16F10 cells Acta Pharmacol Sin. 2022 Jul;43(7):1829-1842
mouse mesenteric artery rings 0.01 to 30 nM ADT-OH caused vasorelaxation in Phe-precontracted mesenteric artery rings, with lower efficacy compared to AP39 and dependent on endothelium. Biomolecules. 2022 Feb 9;12(2):280
Chinese hamster ovary (CHO-K1) cells 30 μM Investigate the subcellular H2S release distribution of ADT-OH, results showed ADT-OH significantly increased H2S levels in mitochondria Anal Chem. 2016 Jun 7;88(11):5769-74
Primary microglia 50 μM 4 h ADT-OH promoted M2 polarization of primary microglia in an AMPK activation- and CaMKKβ-dependent manner Antioxid Redox Signal. 2014 Oct 20;21(12):1741-58
Hela cells 50 μM ADT-OH activated AMPK in LKB1-deficient Hela cells Antioxid Redox Signal. 2014 Oct 20;21(12):1741-58
BV2 microglial cells 50 μM 30 min to 8 h ADT-OH enhanced AMPK activation and suppressed LPS-induced inflammation Antioxid Redox Signal. 2014 Oct 20;21(12):1741-58

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Cisplatin-induced acute kidney injury model Oral 37 mg/kg Once daily for 4 days Evaluate the protective effect of ADT-OH on cisplatin-induced acute kidney injury, results showed ADT-OH significantly improved renal function and mitochondrial function Redox Biol. 2024 Feb;69:102973
C57BL/6 mice B16F10 melanoma model Oral 37.5 mg/kg Once every other day ADT-OH significantly inhibited melanoma growth and prolonged the survival of tumour-bearing mice. Cell Death Dis. 2020 Jan 16;11(1):33
C57BL/6 mice Tail vein injection model Intravenous injection 37.5 mg/kg Five times a week for three weeks ADT-OH significantly inhibited lung metastasis of melanoma cells Acta Pharmacol Sin. 2022 Jul;43(7):1829-1842
CD-1 male mice LPS-induced neuroinflammation model Intraperitoneal injection 50 mg/kg Single dose, 30 minutes before LPS stimulation ADT-OH enhanced AMPK activation in the brain, suppressed M1 gene expression, and promoted M2 gene expression Antioxid Redox Signal. 2014 Oct 20;21(12):1741-58

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.42mL

0.88mL

0.44mL

22.09mL

4.42mL

2.21mL

44.18mL

8.84mL

4.42mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories